|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Transaction costs | |||||
| Other operating expenses | |||||
| Research and development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Financial income (expense): | |||||
| Gain from change in fair value of Warrants | |||||
| Loss on Warrant repurchase/redemption | |||||
| Other financial income (expense), net | |||||
| Financial income (expense), net | |||||
| Income before income taxes | |||||
| Income taxes | |||||
| Net income | |||||
| Other comprehensive income (loss) | |||||
| Unrealized gain (loss) on available-for-sale debt securities, net | |||||
| Tax (expense) benefit on unrealized gain (loss) on available-for-sale debt securities, net | |||||
| Unrealized gain on cash flow hedges, net | |||||
| Tax expense on unrealized gain on cash flow hedges, net | |||||
| Unrealized loss on interest rate floor, net | |||||
| Tax benefit on unrealized loss on interest rate floor, net | |||||
| Foreign currency translation adjustments | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive income | |||||
| Per Share Data | |||||
| Net income per share attributable to common stockholders - Basic earnings per share (in dollars per share) | |||||
| - Diluted earnings per share (in dollars per share) | |||||
| Weighted average common shares outstanding - Basic (in shares) | |||||
| Weighted average common shares outstanding - Diluted (in shares) | |||||
Loading...